Sartorius Stedim BiotechSRTOY -0.50%82 OCF Yield % is 4.49 as of Jun. 28, 2026, which is 100% above its 10-year median of 2.24. GuruFocus rates SRTOY with a GF Score™ of 82/100 and a GF Value™ of $23.65 (Modestly Undervalued). The stock has 5 warning signs investors should review. Among 852 Medical Devices & Instruments companies, Sartorius Stedim Biotech ranks better than 62.79% on this metric.
OCF Yield % is calculated as Cash Flow from Operations divided by Market Capitalization. It is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.
Similar to Earnings Yield %, OCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high operating cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
Sartorius Stedim Biotech OCF Yield % Related Terms
Sartorius Stedim Biotech OCF Yield % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Instruments & Supplies subindustry, Sartorius Stedim Biotech's OCF Yield %, along with its competitors' market caps and OCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sartorius Stedim Biotech OCF Yield % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Sartorius Stedim Biotech's OCF Yield % distribution charts can be found below:
* The bar in red indicates where Sartorius Stedim Biotech's OCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sartorius Stedim Biotech (SRTOY) has a OCF Yield % of 4.49 as of Jun. 28, 2026. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Sartorius Stedim Biotech and its competitors. This is 100% above median its historical median of 2.24. Over the past decade, Sartorius Stedim Biotech's OCF Yield % has ranged from 0.46 to 5.56. According to the industry distribution chart, Sartorius Stedim Biotech ranks #317 out of 852 companies in the Medical Devices & Instruments industry, placing it in the top 37.2%.
Is Sartorius Stedim Biotech's OCF Yield % too high?
Sartorius Stedim Biotech's current OCF Yield % of 4.49 is 100% above median its 10-year median of 2.24. Over the past 10 years, this metric has ranged from a low of 0.46 to a high of 5.56. The Medical Devices & Instruments industry median OCF Yield % is 1.79. Sartorius Stedim Biotech's value of 4.49 is 151.5% above this industry median. Based on the distribution chart, Sartorius Stedim Biotech ranks #317 out of 852 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Sartorius Stedim Biotech has a GF Score™ of 82/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Sartorius Stedim Biotech's OCF Yield % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Sartorius Stedim Biotech ranks #317 out of 852 companies for OCF Yield %. This puts Sartorius Stedim Biotech in the upper half of its industry. The industry median OCF Yield % is 1.79. Sartorius Stedim Biotech's value of 4.49 is 151.5% above this benchmark. Historically, Sartorius Stedim Biotech's own OCF Yield % has ranged from 0.46 to 5.56 over the past decade. While the company's 10-year median is 2.24 vs. the industry median of 1.79, Sartorius Stedim Biotech has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Yield % for a Medical Devices & Instruments company?
The median OCF Yield % among Medical Devices & Instruments companies is 1.79, based on 852 companies in the industry. Companies in the top quartile (top 25%) have a OCF Yield % significantly above this median, while those in the bottom quartile fall well below. However, OCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Sartorius Stedim Biotech's current OCF Yield % of 4.49 is 151.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Yield % mean?
A high OCF Yield % can signal that a stock is expensive relative to its fundamentals. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Sartorius Stedim Biotech and its competitors. For the Medical Devices & Instruments industry, the median OCF Yield % is 1.79 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sartorius Stedim Biotech's current OCF Yield % is 4.49, which is 100% above median its own 10-year median of 2.24. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sartorius Stedim Biotech stock overvalued right now?
Based on GuruFocus' analysis, Sartorius Stedim Biotech (SRTOY) is currently considered Modestly Undervalued. The stock's GF Value™ is $23.65, compared to a current price of $20.09 — trading 15.1% below its estimated fair value. The current OCF Yield % is 4.49, which is 100% above median its 10-year median of 2.24 and 151.5% above the Medical Devices & Instruments industry median of 1.79. Sartorius Stedim Biotech's overall GF Score™ is 82/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Yield % calculated?
OCF Yield % is calculated from a company's financial statements. For Sartorius Stedim Biotech (SRTOY), the current OCF Yield % is 4.49 as of Jun. 28, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Sartorius Stedim Biotech (SRTOY) Overvalued in 2026?
Based on GuruFocus' analysis, Sartorius Stedim Biotech stock appears to be undervalued.
The current stock price of $20.09 is trading 15.1% below its estimated GF Value™ of $23.65.
GuruFocus considers Sartorius Stedim Biotech to be Modestly Undervalued.
Key valuation signals for SRTOY:
OCF Yield %: 4.49 (100% above median its 10-year median of 2.24)
GF Value™: $23.65 vs. price of $20.09 (15.1% below fair value)
Industry Position: 151.5% above the Medical Devices & Instruments median (#317 of 852)
No single metric tells the full story. See the SRTOY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Sartorius Stedim Biotech is a leading provider of bioprocessing solutions. It sells equipment and consumables for fermentation, filtration, fluid management, purification, and cell culture media for manufacturing biologic drugs and has a focus on single-use technology. It is a subsidiary of Sartorius AG, which has 71.5% ownership and 83% voting control. The business is geographically diverse, with 35% of sales from the Americas, 42% from Europe, the Middle East, and Africa, 15% from Asia excluding China, and 8% from China.
82GF Score
Get the complete analysis for SRTOY
OCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SRTOY has been successfully added to your 
